Sugi Predict

Sugi Predict / Compounds / SCHEMBL114467

SCHEMBL114467

SCHEMBL114467

CCOC(=O)C1C(CC)=CCCC1(C)C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ TP53 P04637 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29402949 0.90 ALDH1A1 (0.34) ALDH1A1CYP3A4ALOX15TDP1TP53
SCHEMBL16269292 0.89 ALDH1A1 (0.36) ALDH1A1CYP3A4ALOX15TDP1TP53
SCHEMBL16269291 0.89 ALDH1A1 (0.36) ALDH1A1CYP3A4ALOX15TDP1TP53
SCHEMBL10886192 0.86 CHRM2 (0.36) ALDH1A1CYP3A4ALOX15TDP1TSHR
SCHEMBL10891280 0.85 TSHR (0.36) ALDH1A1CYP3A4ALOX15TDP1TP53
SCHEMBL10648071 0.84 ALDH1A1 (0.48) ALDH1A1CYP3A4ALOX15TDP1TP53
SCHEMBL5265483 0.81 ALDH1A1 (0.40) ALDH1A1CYP3A4ALOX15TDP1
SCHEMBL24220829 0.81 ALDH1A1 (0.39) ALDH1A1CYP3A4ALOX15TDP1TP53
SCHEMBL11524279 0.75 ALDH1A1 (0.39) ALDH1A1TP53TSHRMAPTMEN1
SCHEMBL2264463 0.71 ALDH1A1 (0.40) ALDH1A1TP53TSHRMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 — — US claimed
EP-4655373-A1 BIODEGRADABLE PERFUME COMPOSITION Givaudan SA (CH) 2025-12-03 — — EP claimed
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 — — US claimed
US-20250235136-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-07-24 — — US claimed
EP-4581114-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Novozymes A/S (DK) 2025-07-09 — — EP claimed
US-20250163343-A1 FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT INTERNATIONAL FLAVORES & FRAGRANCES INC. 2025-05-22 — — US claimed
EP-4555060-A1 LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT The Procter & Gamble Company (US) 2025-05-21 — — EP claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 — — US claimed
CN-119698458-A Improvements in or relating to organic compounds improvements relating to organic compounds 诺维信公司 2025-03-25 — — CN claimed
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 — — WO claimed
EP-1716159-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS General Electronic Company (US) 2006-11-02 — — EP claimed
EP-1697386-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES General Electric Company A Corporation of the State of New York (US) 2006-09-06 — — EP claimed
US-20060166857-A1 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes SYMRISE GMBH & CO. KG (DE) 2006-07-27 — — US claimed
WO-2005066187-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GENERAL ELECTRIC COMPANY (US) 2005-07-21 — — WO claimed
WO-2005066186-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS GENERAL ELECTRIC COMPANY (US) 2005-07-21 — — WO claimed
US-20050136021-A1 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 — — US claimed
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 — — US claimed
US-4570648-A Flavorants containing esters of 2,3,6,6-tetramethylcyclohexenyl carboxylic acids GIVAUDAN CORPORATION (US) 1986-02-18 — — US claimed
US-4474687-A PERFUMES, FLAYORS GIVAUDAN CORPORATION (US) 1984-10-02 — — US claimed
US-4113663-A 2-Ethyl-6,6-dimethyl-2-cyclohexene-1-carboxylic acid ethyl ester perfume compositions GIVAUDAN CORPORATION (US) 1978-09-12 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 ALDH1A1 2581/4885CYP3A4 4123/4885ALOX15 2323/4885
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients F9, RPL39, ECPAS ALDH1A1 44/4885CYP3A4 1847/4885ALOX15 868/4885
US-20050136021-A1 Active-releasing cyclic siloxanes F9, RPL39, ALDH16A1 ALDH1A1 57/4885CYP3A4 2149/4885ALOX15 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.